Indications And Dose
HIV infection in combination with other antiretroviral drugs ▶BY MOUTH ▶Adult: 1 tablet twice daily
PDF page 715
Drug reference
HIV infection in combination with other antiretroviral drugs ▶BY MOUTH ▶Adult: 1 tablet twice daily
PDF page 715
Acute porphyrias p. 1120
PDF page 715
Haemophilia (increased risk of bleeding)
PDF page 715
→Appendix 1: lamivudine. zidovudine
PDF page 715
Avoid if eGFR less than 50 mL/minute/1.73 m2 (consult product literature).
PDF page 715
▶Common or very common Alopecia. anaemia. angioedema . anxiety. appetite abnormal. arthralgia. asthenia. diabetes mellitus. diarrhoea. dizziness. dry mouth. dyslipidaemia. dyspnoea. fever. gastrointestinal discomfort. gastrointestinal disorders. headache. hepatic disorders. hypersensitivity. hypertension. malaise. muscle complaints. nausea. neutropenia. oral ulceration. pancreatitis. peripheral neuropathy. seizure. skin reactions. sleep disorders. taste altered. vomiting ▶Uncommon Drowsiness. immune reconstitution inflammatory syndrome. osteonecrosis. Stevens-Johnson syndrome. weight increased
PDF page 715
In general, manufacturers advise use with caution in patients with chronic hepatitis B or C (increased risk of hepatic side-effects). eiiii F above
PDF page 715
COMBIVIR ® TABLETS Tablets may be crushed and mixed with semi-solid food or liquid just before administration.
PDF page 715
There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Zidovudine with lamivudine (Non-proprietary) Lamivudine 150 mg, Zidovudine 300 mg Zidovudine 300mg / Lamivudine 150mg tablets | 60 tablet P £240.10–£255.10 DT = £300.12 ▶Combivir (ViiV Healthcare UK Ltd) Lamivudine 150 mg, Zidovudine 300 mg Combivir 150mg/300mg tablets | 60 tablet P £300.12 DT = £300.12 ANTIVIRALS › PROTEASE INHIBITORS, HIV Protease inhibitors f
PDF page 715
1 tablet twice daily
First-line fragment. Read the complete Indications and Dose section above.
PDF page 715